Edward Thomas Andrews

Edward Thomas Andrews

Auto-generated profile, based on publicly available information

Edward Thomas Andrews

Department of Neonatal Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2018 in Archives of Disease in Childhood - Fetal and Neonatal Edition
Verified
Journal Article
Closed access
PDF file
EAEdward Thomas Andrews
Edward Thomas Andrews
JAJames Ashton
James Ashton
FPFreya Pearson
Freya Pearson
RBR Mark Beattie
R Mark Beattie
MJMark Johnson
Mark Johnson
Background Previously published data have demonstrated that preterm infants experience a fall across marked centile lines for weight in early life with early poor head growth also reported. This study describes a single neonatal unit’s experience of longitudinal change in weight, head circumference (HC) and length in a cohort of preterm infants born <32 weeks’ gestation. Methods Data were collected from a single neonatal unit between July 2012 and June 2017. This period followed the introduction of improved nutritional guidelines. Patients were grouped according to their gestational age at birth. Growth lines were constructed for weight, HC and length in each gestational age group from the median measures and compared with reference centile lines. Results Data were analysed from 396 patients consisting of 2808, 1991 and 2004 measures for weight, HC and length, respectively. Longitudinal growth plots did not show an initial absolute weight loss in any of the subgroups. Across all groups, the mean change in SD score between birth and 36 weeks was −0.27 (95% CI −0.39 to −0.15). Conclusions This description of longitudinal growth in a cohort of preterm infants demonstrates that early postnatal growth failure is not inevitable, with most infants growing along a trajectory close to their birth centile. There is no evidence of a 2 marked centile line weight decrease or weight loss. These data provide evidence to suggest that extrauterine weight gain tracking centile lines can be achieved.

11 May 2021 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
FBFederica Buonocore
Federica Buonocore
AMAvinaash Vickram Maharaj
Avinaash Vickram Maharaj
YQYounus Qamar
Younus Qamar
KKKatrin Koehler
Katrin Koehler
JSJenifer P Suntharalingham
Jenifer P Suntharalingham
JAJohn C Achermann
John C Achermann
Context Although primary adrenal insufficiency (PAI) in children and young people is often due to congenital adrenal hyperplasia (CAH) or autoimmunity, other genetic causes occur. The relative prevalence of these conditions is poorly understood. Objective We investigated genetic causes of PAI in children and young people over a 25 year period. Design, Setting and Participants Unpublished and published data were reviewed for 155 young people in the United Kingdom who underwent genetic analysis for PAI of unknown etiology in three major research centers between 1993 and 2018. We pre-excluded those with CAH, autoimmune, or metabolic causes. We obtained additional data from NR0B1 (DAX-1) clinical testing centers. Intervention and Outcome Measurements Genetic analysis involved a candidate gene approach (1993 onward) or next generation sequencing (NGS; targeted panels, exomes) (2013-2018). Results A genetic diagnosis was reached in 103/155 (66.5%) individuals. In 5 children the adrenal insufficiency resolved and no genetic cause was found. Pathogenic variants occurred in 11 genes: MC2R (adrenocorticotropin receptor; 30/155, 19.4%), NR0B1 (DAX-1; 7.7%), CYP11A1 (7.7%), AAAS (7.1%), NNT (6.5%), MRAP (4.5%), TXNRD2 (4.5%), STAR (3.9%), SAMD9 (3.2%), CDKN1C (1.3%), and NR5A1/steroidogenic factor-1 (SF-1; 0.6%). Additionally, 51 boys had NR0B1 variants identified through clinical testing. Although age at presentation, treatment, ancestral background, and birthweight can provide diagnostic clues, genetic testing was often needed to define the cause. Conclusions PAI in children and young people often has a genetic basis. Establishing the specific etiology can influence management of this lifelong condition. NGS approaches improve the diagnostic yield when many potential candidate genes are involved.

1 December 2019 in Clinical Nutrition
Verified
Journal Article
Closed access
EAEdward T. Andrews
Edward T. Andrews
RBR. Mark Beattie
R. Mark Beattie
MJMark Johnson
Mark Johnson

9 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
OBOthman Bin-Alamer
Othman Bin-Alamer
HAHussam Abou-Al-Shaar
Hussam Abou-Al-Shaar
ZGZachary C. Gersey
Zachary C. Gersey
SHSakibul Huq
Sakibul Huq
JKJustiss A. Kallos
Justiss A. Kallos
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis
Advancements in intraoperative visualization and imaging techniques are increasingly central to the success and safety of brain tumor surgery, leading to transformative improvements in patient outcomes. This comprehensive review intricately describes the evolution of conventional and emerging technologies for intraoperative imaging, encompassing the surgical microscope, exoscope, Raman spectroscopy, confocal microscopy, fluorescence-guided surgery, intraoperative ultrasound, magnetic resonance imaging, and computed tomography. We detail how each of these imaging modalities contributes uniquely to the precision, safety, and efficacy of neurosurgical procedures. Despite their substantial benefits, these technologies share common challenges, including difficulties in image interpretation and steep learning curves. Looking forward, innovations in this field are poised to incorporate artificial intelligence, integrated multimodal imaging approaches, and augmented and virtual reality technologies. This rapidly evolving landscape represents fertile ground for future research and technological development, aiming to further elevate surgical precision, safety, and, most critically, patient outcomes in the management of brain tumors.

1 October 2019 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
EAEdward T. Andrews
Edward T. Andrews
JAJames Ashton
James Ashton
FPFreya Pearson
Freya Pearson
RBR. Mark Beattie
R. Mark Beattie
MJMark Johnson
Mark Johnson

26 April 2024 in Surgical Neurology International
Verified
Journal Article
Open access
NSNikhil Sharma
Nikhil Sharma
AMArka N. Mallela
Arka N. Mallela
TKTalha Khan
Talha Khan
SCStephen P Canton
Stephen P Canton
NKNicolas Matheo Kass
Nicolas Matheo Kass
EAEdward G. Andrews
Edward G. Andrews
Background: Augmented reality (AR) applications in neurosurgery have expanded over the past decade with the introduction of headset-based platforms. Many studies have focused on either preoperative planning to tailor the approach to the patient’s anatomy and pathology or intraoperative surgical navigation, primarily realized as AR navigation through microscope oculars. Additional efforts have been made to validate AR in trainee and patient education and to investigate novel surgical approaches. Our objective was to provide a systematic overview of AR in neurosurgery, provide current limitations of this technology, as well as highlight several applications of AR in neurosurgery. Methods: We performed a literature search in PubMed/Medline to identify papers that addressed the use of AR in neurosurgery. The authors screened three hundred and seventy-five papers, and 57 papers were selected, analyzed, and included in this systematic review. Results: AR has made significant inroads in neurosurgery, particularly in neuronavigation. In spinal neurosurgery, this primarily has been used for pedicle screw placement. AR-based neuronavigation also has significant applications in cranial neurosurgery, including neurovascular, neurosurgical oncology, and skull base neurosurgery. Other potential applications include operating room streamlining, trainee and patient education, and telecommunications. Conclusion: AR has already made a significant impact in neurosurgery in the above domains and has the potential to be a paradigm-altering technology. Future development in AR should focus on both validating these applications and extending the role of AR.